Feng, Gong http://orcid.org/0000-0001-5394-0029
Valenti, Luca http://orcid.org/0000-0001-8909-0345
Wong, Vincent Wai-Sun http://orcid.org/0000-0003-2215-9410
Fouad, Yasser Mahrous http://orcid.org/0000-0001-7989-5318
Yilmaz, Yusuf http://orcid.org/0000-0003-4518-5283
Kim, Won http://orcid.org/0000-0002-2926-1007
Sebastiani, Giada
Younossi, Zobair M.
Hernandez-Gea, Virginia http://orcid.org/0000-0001-7937-984X
Zheng, Ming-Hua http://orcid.org/0000-0003-4984-2631
Article History
Accepted: 5 September 2023
First Online: 5 October 2023
Competing interests
: L.V. reports consulting fees from Gilead Sciences, Pfizer, AstraZeneca, Novo Nordisk, Intercept pharmaceuticals, Diatech Pharmacogenetics, IONIS and Viatris; honoraria from MSD, Gilead Sciences, AlfaSigma, AbbVie and Resalis; and grants from Gilead Sciences. V.W.-S.W. reports grants from Gilead Sciences; consulting fees from AbbVie, Boehringer Ingelheim, Echosens, Gilead Sciences, Intercept, Inventiva, Novo Nordisk, Pfizer and TARGET PharmaSolutions; and honoraria for lectures from Abbott, AbbVie, Gilead Sciences and Novo Nordisk; and is Chairman of Subspecialty Board of Gastroenterology and Hepatology, Hong Kong College of Physicians, and Co-founder of Illuminatio Medical Technology. Y.Y. is a consultant to Zydus, Cymabay and Novo Nordisk. W.K. reports grants from GSK, Gilead Sciences, Novartis, Pfizer, Roche, Springbank, Ildong, Galmed, Dicerna, Enyo, Hanmi, Novo Nordisk and KOBIOLABS; reports consulting fees from Boehringer Ingelheim, Novo Nordisk, Standigm, Daewoong, TSD Life Sciences, Ildong, Olix Pharma, HK Inoen and KOBIOLABS; honoraria for lectures from Ildong, Samil and Novo Nordisk; owns stocks in KOBIOLABS and Lepidyne; and is the founder of Remedygen. G.S. reports honoraria from Merck, Gilead Sciences, Abbvie, Intercept, Novo Nordisk and Pfizer; and unrestricted research funding from Theratechnologies. Z.M.Y. is a consultant to BMS, Gilead Sciences, AbbVie, Intercept and GSK. V.H.-G. reports honoraria for lectures from GORE and Cook Medical. M.-H.Z. and Y.M.F. declare no competing interests.